Списки джерел: "DIGPD"

1

Létourneau-Montminy, Marie-Pierre, and Theophane de Rauglaudre. "PSIX-18 Prediction of urinary P excretion as a tool to assess mineral status of growing pigs." Journal of Animal Science 98, Supplement_3 (November 2, 2020): 182–83. http://dx.doi.org/10.1093/jas/skaa054.323.

Повний текст джерела

Анотація:

Abstract Urinary losses of phosphorus (P) and calcium (Ca) are indicators of absorbed compared to amount needed for tissue growth as well as their balance for bone deposition. They can thus be a good indicator of the mineral status. This hypothesis has been validated through meta-analysis using a database of P and Ca retention in growing pigs including 43 publications published between 1969 and 2018 for a total of 51 experiments and 251 dietary treatments. P urinary excretion has been simulated using a multiple regression analysis with the proc MIXED (Minitab® 19) with trial effect as random. Average body weight of the pigs was 32kg ±18kg. Urinary P losses (urineP) was influenced by apparent digestible P (digP, recalculated for each treatment; g/kg), total Ca (Ca, g/kg), and microbial phytase (PhytM, FTU/kg). The model created explains 90% of urineP (R2 = 91%). UrineP was increased with digP from about 2 g/kg of digP (digP, P = 0.02, digP x digP, P < 0.001), before this point it was very low. Increasing dietary Ca decreased urineP linearly when exceeding the 2 g/kg of digP (Ca x digP, P < 0.001); P can then be fixed into bone as hydroxyapatite. The contribution of P is thus to manage in conjunction with dietary Ca. PhytM effect depends of both Ca and P (PhytM x Ca x digP; P = 0.03) showing that phytM addition reduces urineP depending of digP and Ca. As an example, in 6 g Ca/kg diet, 500 FTU/kg addition reduce urineP by 28% in 2 g digP/kg and by only 4% in 4 g digP g/kg. This is due to a better retention of P into bone in low digP. Next step will be urinary Ca modeling and then looking at meaning of their ratio in relation to mineral status to develop a practical tool to assess Ca and P status of pig.

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Parker, Gordon, Stacey McCraw, and Adam Bayes. "Borderline personality disorder: does its clinical features show specificity to differing developmental risk factors?" Australasian Psychiatry 26, no. 4 (March 13, 2018): 410–13. http://dx.doi.org/10.1177/1039856218760732.

Повний текст джерела

Анотація:

Objectives: To determine if differing developmental factors show specificity to differing manifestations of borderline personality disorder (BPD). Methods: A clinical sample of 73 females diagnosed with BPD undertook a psychiatrist interview and completed self-report questionnaires, including the semi-structured Diagnostic Interview for DSM-IV Personality Disorders (DIPD-IV) assessing for BPD status. A set of negative and potentially traumatic developmental factors were included in the assessment. Results: Childhood sexual abuse, affirmed by 49% of the sample, showed specificity in being linked with DIPD-defined affective instability. DIPD-defined identity disturbance also showed specificity in being associated only with reporting significant non-sexual developmental trauma. DIPD-defined anger and paranoia/dissociation showed minimal specificity and were associated with most antecedent developmental factors in adulthood. Conclusions: Differing manifestations of BPD are likely to be shaped by specific and non-specific developmental events. Clarification of such links has the potential to shape more specific therapeutic interventions.

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Borissevitch, Iouri E., Christiane P. F. Borges, Galina P. Borissevitch, Victor E. Yushmanov, Sonia R. W. Louroh, and Marcel Tabak. "Binding and Location of Dipyridamole Derivatives in Micelles: the Role of Drug Molecular Structure and Charge." Zeitschrift für Naturforschung C 51, no. 7-8 (August 1, 1996): 578–90. http://dx.doi.org/10.1515/znc-1996-7-818.

Повний текст джерела

Анотація:

Abstract Binding and localization of the vasodilator and antitumor drug coactivator dipyridamole (DIP) and of its three derivatives, RA14. RA47 and RA25 (DIPD), to cationic (cetyltrimethylammonium chloride), anionic (sodium dodecylsulfate), zwitterionic (N-hexadecyl-N,N-di-methyl-3-ammonio-1-propanesulfonate), and neutral (t-octylphenoxypolyethoxyethanol) micelles was studied using fluorescence, optical absorption and 1H NMR spectroscopy. The analysis of NMR, optical absorption and fluorescence data indicates that the depth of localization of the drugs in the micelles from the surface decreased in the order DIP > RA14 > RA47 > RA25. The binding constants for the neutral drug forms change in the same order in the range of 1400-3100 м-1 for DIP to 80-300 м-1 for RA25. This order is identical with the reported biological activity of DIPD. For the protonated drugs in zwitterionic or neutral micelles the binding constants are reduced by a factor of 20-75.

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Bernardo, Ana Paula, M. Auxiliadora Bajo, Olivia Santos, Gloria Del Peso, Maria João Carvalho, António Cabrita, Rafael Selgas, and Anabela Rodrigues. "Two-in-One Protocol: Simultaneous Small-Pore and Ultrasmall-Pore Peritoneal Transport Quantification." Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 32, no. 5 (September 2012): 537–44. http://dx.doi.org/10.3747/pdi.2011.00175.

Повний текст джерела

Анотація:

BackgroundReduced free water transport (FWT) through ultrasmall pores contributes to net ultrafiltration failure (UFF) and should be seen as a sign of more severe functional deterioration of the peritoneal membrane. The modified peritoneal equilibration test (PET), measuring the dip in dialysate Na concentration, estimates only FWT. Our aim was to simultaneously quantify small-solute transport, FWT, and small-pore ultrafiltration (SPUF) during a single PET procedure.MethodsWe performed a 4-hour, 3.86% glucose PET, with additional measurement of ultrafiltration (UF) at 60 minutes, in 70 peritoneal dialysis patients (mean age: 50 ± 16 years; 61% women; PD vintage: 26 ± 23 months). We calculated the dialysate-to-plasma ratios (D/P) of creatinine and Na at 0 and 60 minutes, and the Na dip (DipD/PNa60,), the delta dialysate Na 0–60 (ΔDNa0–60), FWT, and SPUF.ResultsSodium sieving (as measured by ΔDNa0–60) correlated strongly with the corrected DipD/PNa60, ( r = 0.85, p < 0.0001) and the corrected FWT ( r = 0.41, p = 0.005). Total UF showed better correlation with FWT than with indirect measurements of Na sieving ( r = 0.46, p < 0.0001 for FWT; r = 0.360, p < 0.0001 for DipD/PNa60,). Corrected FWT fraction was 0.45 ± 0.16. A negative correlation was found between time on PD and both total UF and FWT ( r = -0.253, p = 0.035 and r = -0.272, p = 0.023 respectively). The 11 patients (15.7%) diagnosed with UFF had lower FWT (89 mL vs 164 mL, p < 0.05) and higher D/P creatinine (0.75 vs 0.70, p < 0.05) than did the group with normal UF. The SPUF correlated positively with FWT in the normal UF group, but negatively in UFF patients ( r = -0.709, p = 0.015). Among UFF patients on PD for a longer period, 44.4% had a FWT percentage below 45%.ConclusionsMeasurement of FWT and SPUF is feasible by simultaneous quantification during a modified 3.86% glucose PET, and FWT is a decisive parameter for detecting causes of UFF in addition to increased effective capillary surface.

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Kumar, Anupama Deepa, Michelle Padilla, Lin Liu, Minya Pu, Emily Pittman, Dimitrios Tzachanis, Sarah Marie Larson, et al. "Phase II study of the combination of daratumumab, ixazomib, pomalidomide, and dexamethasone as salvage therapy in relapsed/refractory multiple myeloma: Stage 2 interim results." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 8041. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.8041.

Повний текст джерела

Анотація:

8041 Background: The combination of daratumumab (Dara), pomalidomide (POM), and dexamethasone (dex) (DPd) has previously demonstrated deep and durable responses including high rates of minimal residual disease (MRD) negativity, in patients with relapsed/refractory (R/R) MM. Quadruplet regimens may further improve results. We report updated findings from a phase 2 multicenter trial of the addition of ixazomib to DPd (DIPd) in patients with early R/R MM. Methods: This is a prospective, multi-center, open-label, single arm phase II trial with a primary objective to evaluate the overall response rate (ORR), safety, and efficacy of DIPd. Secondary endpoints include progression-free survival (PFS), overall survival (OS), and MRD-negativity rate. A Simon’s optimal 2-stage design was used, with 14 subjects in stage 1 to assess response and 32 patients for stage 2. Eligible patients may not have had exposure Dara or ixazomib, may not have progressed on POM, and may have received ≥1 and ≤3 prior lines of therapy. The first six patients in the safety run-in received Dara 16mg/kg IV weekly x 8 doses, biweekly x 8 doses, then monthly, POM 4mg orally on days 1-21 of a 28-day cycle, ixazomib 4mg orally on days 1,8,15 every 28 days, and dex 20-40mg weekly. Grade 3-4 neutropenia was observed in 100% of patients, prompting dose reduction to ixazomib 3 mg and POM 3 mg by the DSMB. An amendment allowed subcutaneous Dara administration. MRD assessments are being performed by EuroFlow for patients in VGPR or suspected CR. Pharmacodynamic changes in patients’ tumor microenvironments were established by custom panel mass cytometry to include T-cell memory and activated subpopulations, B-cell content, NK-cell subpopulations as well as MDSCs, Tregs and T-exhaustive markers, monocytes and dendritic cells. Results: To date, 14 subjects have been treated in stage 1, and 18 patients in stage 2. Median age was 61.5 (range 41-87) years, 50% were female and 72% white. Median number of prior regimens was 1 (range 1-3), all patients were lenalidomide-exposed, and 47% (11/23) had high-risk cytogenetic features. The most common grade 3-4 treatment emergent adverse events included neutropenia (78%), infection (30%), leukopenia (11%), respiratory conditions (7%), psychiatric disturbance (4%), and thrombosis (4%). Median time on treatment was 4 months (1-29), with 11 patients remaining on DIPd and 5 deaths (4 due to progressive disease and 1 due to sepsis). ORR to date was 84% (16/19), and the best responses included: 5 (26%) sCR; 4 (21%) VGPR; 7 (37%) PR. After a median follow up of 12 months, the median OS was 39 months and PFS was 9.5 months. Conclusions: The quadruplet regimen DIPd is a well-tolerated combination that has shown early safety, efficacy, and ORR in early R/R myeloma, including patients with high-risk genetic abnormalities. Clinical trial information: NCT03590652.

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Kato, Kaori, Dai Yamanouchi, Karla Esbona, Kentaro Kamiya, Fan Zhang, K. Craig Kent та Bo Liu. "Caspase-mediated protein kinase C-δ cleavage is necessary for apoptosis of vascular smooth muscle cells". American Journal of Physiology-Heart and Circulatory Physiology 297, № 6 (грудень 2009): H2253—H2261. http://dx.doi.org/10.1152/ajpheart.00274.2009.

Повний текст джерела

Анотація:

Apoptotic death of vascular smooth muscle cells (SMCs) is a prominent feature of blood vessel remodeling and various vascular diseases. We have previously shown that protein kinase C-δ (PKC-δ) plays a critical role in SMC apoptosis. In this study, we tested the importance of PKC-δ proteolytic cleavage and tyrosine phosphorylation within the apoptosis pathway. Using hydrogen peroxide as a paradigm for oxidative stress, we showed that proteolytic cleavage of PKC-δ occurred in SMCs that underwent apoptosis, while tyrosine phosphorylation was detected only in necrotic cells. Furthermore, using a peptide (z-DIPD-fmk) that mimics the caspase-3 binding motif within the linker region of PKC-δ, we were able to prevent the cleavage of PKC-δ, as well as apoptosis. Inhibition of PKC-δ with rottlerin or small-interfering RNA diminished caspase-3 cleavage, caspase-3 activity, cleavage of poly (ADP-ribose) polymerase, cleavage of PKC-δ, and DNA fragmentation, confirming the previously reported role of PKC-δ in initiation of apoptosis. In contrast, z-DIPD-fmk markedly diminished caspase-3 activity, cleavage of PKC-δ, and DNA fragmentation without affecting cleavage of caspase-3 and poly (ADP-ribose) polymerase. Taken together, our data suggest that caspase-3-mediated PKC-δ cleavage underlies SMC apoptosis induced by oxidative stress, and that PKC-δ acts both upstream and downstream of caspase-3.

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Li, Xiao Gen, Zhi Quan Huang, Tong Jiang, and An Ming Wang. "Analysis of Constructing 3-Dimensional Virtual Scene Technique Based on DEM." Advanced Materials Research 271-273 (July 2011): 404–9. http://dx.doi.org/10.4028/www.scientific.net/amr.271-273.404.

Повний текст джерела

Анотація:

High resolution DEM(Digital Elevation Model, DEM) is created based on original CAD terrain map (one reservoir as example). Then the article offers precision analysis、topographic factors analysis、visibility analysis、reservoir volume and submerging acreage computing. Then adopting GeoVRML technique is to implement the functions of WebGIS 、visualization and query of computing result、graph data visualization and reservoir region virtual scene roaming etc. The system implements deep administrative levels information diged and long-distance visualization expression. The result shows on the basic high resolution DEM to realize 3-Dimensional Visualization Analyse and calculation functions and compress the spatial data to release these data in the WebGIS(Web Geographical Information System, WebGIS) as well as.

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Xiaofeng, Liu, Li Lianfang, Chen Fei, Li Yuming, Chen Hui, Li Qing, Cheng Lu, and Cui Shude. "An Intraoperative Localization Technique for a Postexcision Specimen of Nonpalpable Breast Calcifications: A Pilot Study." American Surgeon 77, no. 11 (November 2011): 1467–71. http://dx.doi.org/10.1177/000313481107701135.

Повний текст джерела

Анотація:

The specimens obtained through excisional biopsy (EB) are commonly large in size and it is difficult to remove the tissues containing nonpalpable calcifications accurately from them for pathologic examination. Therefore, the aim of the study is to develop a novel method of subarea localization technique (SLT) for sampling from the postexcisional specimens. A retrospective clinical study of 48 consecutive patients with breast microcalcifications were divided into a study group (n = 24 patients, 25 breasts) and a control group (n = 24 patients, 24 breasts) in time sequence. The specimens of study group were localized by SLT performed by cutting lines and/or metallic markers. The main study end points were the duration of intraoperative pathologic diagnosis (DIPD) and duration of conclusive pathology diagnosis (DCPD). The number of frozen blocks, number of paraffin blocks, number of sections, and other parameters correlated with pathologic diagnosis were compared between the two groups. SLT was succeeded in 48 of 48 (100%) patients, which shortened DIPD (29.3 vs 45.5 minutes, P < 0.01) significantly with less frozen blocks (6.2 vs 12.6, P < 0.01) and less frozen sections (8.5 vs 13.7, P = 0.01) than that of the control group. Moreover, SLT shortened DCPD (4.1 vs 5.1 days, P = 0.02) with less paraffin blocks (12.2 vs 21.7, P < 0.01) and less paraffin sections (20.0 vs 39.9, P < 0.01) than that of the control group. SLT decreased workload of the specimens sampling procedure and SLT may be recommended as a reliable specimens sampling method to guide pathology test for EB specimens containing calcifications.

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Grilo, C., M. Pagano, and R. Stout. "Do Stressful Life Events Predict Eating Disorder Relapse?: Six-year Outcomes from the Collaborative Personality Disorders Study." European Psychiatry 24, S1 (January 2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)70615-7.

Повний текст джерела

Анотація:

Aims:To examine the natural course of eating disorders (ED) prospectively over 6 years and to examine link between stressful life events (SLEs) and ED relapse among women with personality-disorders (PDs).Method:Subjects were 132 female patients with bulimia nervosa (N=40) or EDNOS (N=92) in the Collaborative Longitudinal Personality Disorders Study. EDs were assessed with the Structured Clinical Interview for DSM-IV Axis-I, and monitored with the Longitudinal Interval Follow-up Evaluation during follow-up. PDs were assessed with the Diagnostic Interview for DSM-IV PD (DIPD-IV), and monitored with the Follow-Along version of the DIPD-IV during follow-up. SLEs were assessed with the Life Events Assessment (LEA). Follow-up assessments were conducted at 6- and 12-months and then yearly through 72 months. Proportional hazard regression analyses were performed to examine the link between time-varying levels of SLEs and ED relapse. Cox regressions controlled for the same covariates used in prior work: duration of ED, number of co-morbid psychiatric disorders, and time-varying status of PDs.Results:Of the 132 patients, 59% had remissions from ED, 68% of whom subsequently relapsed over the course of 6 years (BN and EDNOS did not differ in relapse). Total number of negative SLEs reported by ED patients significantly predicted subsequent ED relapse (HazardRatio=1.5, p< .05). The types of SLEs that predicted ED relapse were elevated work stressors (HazardRatio=3.0, p< .01) and elevated recreation stressors (HazardRatio=3.1, p< .05).Conclusion:Higher work stress and higher recreation stress represent significant warning signs for triggering relapse for women in remission from BN and EDNOS.

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Grilo, C., M. Pagano, and R. Stout. "Do Stressful Life Events Predict Eating Disorder Relapse?: Six-year Outcomes from the Collaborative Personality Disorders Study." European Psychiatry 24, S1 (January 2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)70979-4.

Повний текст джерела

Анотація:

Aims:To examine the natural course of eating disorders (ED) prospectively over 6 years and to examine link between stressful life events (SLEs) and ED relapse among women with personality-disorders (PDs).Method:Subjects were 132 female patients with bulimia nervosa (N=40) or EDNOS (N=92) in the Collaborative Longitudinal Personality Disorders Study. EDs were assessed with the Structured Clinical Interview for DSM-IV Axis-I, and monitored with the Longitudinal Interval Follow-up Evaluation during follow-up. PDs were assessed with the Diagnostic Interview for DSM-IV PD (DIPD-IV), and monitored with the Follow-Along version of the DIPD-IV during follow-up. SLEs were assessed with the Life Events Assessment (LEA). Follow-up assessments were conducted at 6- and 12-months and then yearly through 72 months. Proportional hazard regression analyses were performed to examine the link between time-varying levels of SLEs and ED relapse. Cox regressions controlled for the same covariates used in prior work: duration of ED, number of co-morbid psychiatric disorders, and time-varying status of PDs.Results:Of the 132 patients, 59% had remissions from ED, 68% of whom subsequently relapsed over the course of 6 years (BN and EDNOS did not differ in relapse). Total number of negative SLEs reported by ED patients significantly predicted subsequent ED relapse (HazardRatio=1.5, p< .05). The types of SLEs that predicted ED relapse were elevated work stressors (HazardRatio=3.0, p< .01) and elevated recreation stressors (HazardRatio=3.1, p< .05).Conclusion:Higher work stress and higher recreation stress represent significant warning signs for triggering relapse for women in remission from BN and EDNOS.

Стилі APA, Harvard, Vancouver, ISO та ін.

Добірка наукової літератури з теми "DIGPD"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Зміст

Статті в журналах з теми "DIGPD"

Книги з теми "DIGPD"